2005
DOI: 10.1016/j.procbio.2004.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Correlation between key enzyme activities in the inosine synthetic pathway and inosine production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…5), and was inhibited strongly and specifically by purine compounds (Chu et al, 2005). The accumulation of PRPP also decreased the PRRR synthetase activity under the same conditions (Henderson et al, 1975).…”
Section: Screening Of 8-ag-resistant Mutantsmentioning
confidence: 90%
See 1 more Smart Citation
“…5), and was inhibited strongly and specifically by purine compounds (Chu et al, 2005). The accumulation of PRPP also decreased the PRRR synthetase activity under the same conditions (Henderson et al, 1975).…”
Section: Screening Of 8-ag-resistant Mutantsmentioning
confidence: 90%
“…New substance formed after implantation might affect the activity of enzymes involved in cAMP metabolism (Gu et al, 2006). IMP dehydrogenase is an important enzyme in the ribonucleotide synthetic pathway and converts IMP to GMP (Chu et al, 2005). The presence of this enzyme adversely affects accumulation of cAMP.…”
Section: Changes In Key Enzyme Activities In Camp Biosynthesismentioning
confidence: 99%
“…Considering the carbon balance, it was deduced that some intermediates of metabolism, such as amino acids, organic acids, or some other nitrogenous substances, had accumulated, and the metabolic flux had shifted to synthesis of these intermediates, other than guanosine. As evidenced by the time-course of by-products, key enzymatic activities, and stoichiometric calculation of metabolic flux shift, it was concluded that late-phase production of guanosine competed against alanine accumulation, which provided possible direction for metabolic engineering and also for process optimization [6,34,35]. Another successful case was the optimization of recombinant human serum albumin by an engineered P. pastoris.…”
Section: Process Optimization In the Context Of Association Analysis mentioning
confidence: 99%
“…Inosine (C 10 H 12 N 4 O 5 ; CAS no. 58-63-9; molecular weight, 268.23 g·mol –1 ; IUPAC name, 9-((2 R ,3 R ,4 S ,5 R )-3,4-dihydroxy-5-(hydroxymethyl)­oxolan-2-yl)-3 H -purin-6-one; molecular structure shown in Figure S1 of the Supporting Information) is known as hypoxanthine or hypoxanthine nucleoside, which is a nucleoside derived from a purine derivative antimetabolite, containing both a polar furan ring and an apolar aromatic group. As we know, nucleoside derivatives have been extensively investigated due to their potential activity as antibiotics, enzyme inhibitors, anticancer, antiviral agents, and ATP generation. It is an important component of ribonucleic acids, with the hydrophilic–hydrophobic balance of the molecule contributing to their conformational stability, which has a great impact role on a large number of various chemical and biological reactions and other areas. ,, …”
Section: Introductionmentioning
confidence: 99%